We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Fed Independence Concerns Weigh on Equities as Commodities Rally

Market Movers :On Friday, the top gainers were Rich Sparkle Holdings Limited (+258.88%), followed by NovaBay Pharmaceuticals, Inc. (+102.54%). On the contrary, Aclarion, Inc. (-41.49%), and ATLAS CRITICAL MINERALS CORPORATION (-41.33%) declined the most the same day.

Team Kalkine | 12 January 2026

US Banking Stocks Slide, BNPL Rises on Credit-Rate Cap Talk Ahead of Earnings

U.S. financial stocks opened sharply lower inpre-market trading Mondayafter former President and 2024–25 Republican nomineeDonald Trump announced a proposal to cap credit card interest rates at 10% for one year— a level significantly below current average rate. The move rattled investors, driving heavy selling …

Team Kalkine | 12 January 2026

What’s Behind Rich Sparkle (NASDAQ:ANPA) 259% Stock Gain?

Rich Sparkle Holdings Limited (NASDAQ:ANPA) is a Hong Kong–based financial printing and corporate services provider. Its services primarily include the preparation and printing of listing documents, financial reports, fund documents, circulars, and announcements. The company serves a wide array of corporate clients, focusing on …

Team Kalkine | 11 January 2026

AI Data Centre Boom Sends Applied Digital Stock Up 18%; Is it lucrative to Buy now?

Applied Digital (NASDAQ:APLD) reported fiscal second-quarterrevenueof USD 126.6M, representing a 250% increase from the prior year. The high-performance computing (HPC) segment contributed USD 85M, with USD 73M coming from tenant fit-out services for large clients, mainly CoreWeave. While these services carry lowergross margins, they …

Team Kalkine | 11 January 2026

Which Healthcare Name Bags a Strong Buy Rating from Wall Street Zen?

In a recent sequence of research notes, several brokerages and ratings services updated their assessments ofKORU Medical Systems, Inc. (NASDAQ:KRMD), reflecting a range of opinions on the medical device maker’s prospects. On Monday, investment analysis firmWall Street Zenrevised its view on KRMD, moving the …

Aditi Sarkar | 11 January 2026

NVDA, NFLX, META -Tech Leaders to Track Amid AI and Advertising Momentum

As the calendar turns to 2026, markets are entering a period that has historically seen increased investor activity. January often attracts fresh equity inflows from retirement contributions, bonuses, and portfolio rebalancing, making it a closely watched month for large-cap stocks.

Team Kalkine | 11 January 2026

This Retail Stock Steps into Nasdaq-100 as AstraZeneca Takes an Exit

According to NASDAQ,Walmart Inc. (NYSE:WMT)will be added to theNasdaq-100Indexand a number of related benchmarks, replacingAstraZeneca, with the changes scheduled to take effect onJanuary 20, 2026. The exchange operator noted the update will be implementedbefore the market opens on Tuesday, the first trading day following …

Team Kalkine | 11 January 2026

Can Constellation Energy (NASDAQ:CEG) Meet Rising AI Power Demands?

Constellation Energy (NASDAQ:CEG) is drawing attention amid growing discussions around the infrastructure required to support artificial intelligence (AI) expansion, particularly the electricity needed to operate large-scale computing systems. While AIinvestmentconversations often focus on semiconductor hardware and data centres, electricity generation remains a key underlying …

Team Kalkine | 11 January 2026

Global Markets Brief: U.S. Equities Edge Higher Ahead of Jobs Data as Commodities Rally and Dollar Firms

Market Movers:On Thursday, the top gainers were flyExclusive, Inc. (+130.25%), followed by Creative Global Technology Holdings Limited (+118.10%). On the contrary, Kustom Entertainment, Inc. (-63.80%), and Immuneering Corporation (-43.22%) declined the most the same day.

Team Kalkine | 09 January 2026

Is Coya Therapeutics a (NASDAQ:BUY) Buy Based on Latest Analyst Ratings?

Coya Therapeutics (NASDAQ:COYA) remains under analyst coverage following a research note from Chardan Capital, which reaffirmed its “buy” rating on the stock, according to a report cited by Benzinga. The brokerage maintained a price target of USD 14.00, referencing its assessment of the company’s …

Aditi Sarkar | 09 January 2026
Support

Hi! How can we help you today?

Loading…